Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody
Jonathan D Santoro1,2,3,4, Tanuja Chitnis1,2
1Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States.
Abstract:
Acute disseminated encephalomyelitis (ADEM) is a common yet clinically heterogenous syndrome characterized by encephalopathy, focal neurologic findings, and abnormal neuroimaging. Differentiating ADEM from other demyelinating disorders of childhood can be difficult and appropriate interpretation of the historical, clinical, and neurodiagnostic components of a patient's presentation is critical. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases are a recently recognized set of disorders, which include ADEM presentations, among other phenotypes. This review article discusses the clinical diagnosis, differential diagnosis, interpretation of data, and treatment/prognosis of this unique syndrome with distinctive review of the spectrum of MOG antibodies.
Insights
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disorder presenting with encephalopathy and focal neurological deficits. Recognizing myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases is crucial for accurate diagnosis and management.
Area of Science:
- Neuroscience
- Immunology
- Pediatric Neurology
Background:
- Acute disseminated encephalomyelitis (ADEM) is a clinically diverse neurological syndrome.
- Distinguishing ADEM from other childhood demyelinating diseases requires careful evaluation.
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases represent a newly identified category of disorders.
Purpose of the Study:
- To review the clinical diagnosis and differential diagnosis of ADEM.
- To discuss the interpretation of diagnostic data in ADEM.
- To outline the treatment and prognosis of ADEM, focusing on MOG antibody spectrum.
Main Methods:
- Literature review of ADEM and MOG antibody-associated diseases.
- Analysis of clinical presentations, neuroimaging, and diagnostic criteria.
- Synthesis of current understanding of MOG antibody spectrum and its relation to ADEM.
Main Results:
- ADEM diagnosis is challenging due to its heterogeneity.
- MOG antibody-associated diseases encompass ADEM and other phenotypes.
- Understanding MOG antibodies is key to managing specific demyelinating conditions.
Conclusions:
- Accurate diagnosis of ADEM relies on integrating historical, clinical, and neurodiagnostic information.
- Myelin oligodendrocyte glycoprotein antibody testing is essential for identifying a subset of ADEM cases.
- This review provides a comprehensive overview for clinicians managing ADEM and MOG-related disorders.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Design Consideration
The factor of safety is another key...
Protein-protein Interfaces
Tensile Strength Considerations of Concrete
The dimensions and shape of a concrete specimen...

